6533b7dbfe1ef96bd126f7e1
RESEARCH PRODUCT
Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting.
D PratiA GasbarriniF MazzottaE SagnelliG CarosiN AbresciaAlfredo AlbertiS AmbuP AndreoneA AndriulliM AngelicoG AntonucciA AscioneLs BelliR BrunoS BrunoPatrizia BurraC CammaN CaporasoG CaritiU CilloN CoppolaA CraxiA De LucaE De MartinV Di MarcoS FagiuoliC FerrariGb GaetaM GalliA GriecoP GrossiA LicataI MaidaA MangiaN MarinoR MaseratiG MissaleM MondelliP NastaG NiroM PersicoE PetrelliA PicciottoF PiscagliaT PollicinoD PratiC PuotiM PuotiG RaimondoMg RumiE SagnelliT SantantonioA SmedileG SquadritoGs BaroniG TalianiM TavioM TotiF BoninoMr BrunettoB CacopardoM CaremaniR CaudaM ColomboG Di PerriF DonatoP FarciG FattovichG FiliceF GhinelliV GuadagninoA LazzarinM LevreroG LicataA OraniA PaffettiG PastoreF PiccininoE PizzigalloPatrizia PontissoV PortelliM RizzettoA RossiT StroffoliniE UbaldiD PratiA GasbarriniT SantantanioA. AlbertiMg RumiS BrunoS FagiuoliP GrossiR BrunoGb GaetaGf AntonucciC PuotiC CammaA. Craxisubject
Liver CirrhosisANTIVIRAL TREATMENTHuman immunodeficiency virus (HIV)HIV InfectionsHepacivirusANTIVIRAL THERAPY; PEGYLATED INTERFERON-ALPHA-2B; LIVER-TRANSPLANTATION; PEGINTERFERON ALPHA-2A; HIV-INFECTED PATIENTS; VIRUS-COINFECTED PATIENTS; RAPID VIROLOGICAL RESPONSEAntiviral therapymedicine.disease_causeGastroenterologyPolyethylene GlycolsHBVguidelinesAcute hepatitisChronic hepatitisSettore MED/12 - Gastroenterologialiver transplantationGastroenterologyAntiviral therapyHepatitis CVIRUS-COINFECTED PATIENTSLIVER-TRANSPLANTATIONHepatitis CRecombinant Proteinsacute hepatitis; antiviral therapy; chronic hepatitis; cirrhosis; elderly patients; hbv; hcv; hdv; hiv; liver transplantationCLINICAL PRACTICE GUIDELINESCirrhosisHCVDrug Therapy CombinationAntiviral therapy Acute hepatitis Chronic hepatitisCirrhosis Elderly patients HBV HCV HDV HIV Liver transplantationElderly patientAcute hepatitiAcute hepatitismedicine.medical_specialtyGenotypePEGINTERFERON ALPHA-2AAlpha interferonHIV-INFECTED PATIENTSInterferon alpha-2CHRONIC HEPATITIS CAntiviral AgentsHepatitis B ChronicChronic hepatitisInternal medicineHDVDrug Resistance ViralRibavirinmedicineHumansPEGYLATED INTERFERON-ALPHA-2BCirrhosiHepatologybusiness.industrySettore MED/09 - MEDICINA INTERNAInterferon-alphaHIVHepatitis C Chronicmedicine.diseaseElderly patientsFamily medicineExpert opinionAntiviral therapy; Acute hepatitis; Chronic hepatitis; Cirrhosis; Elderly patients; HBV; HCV; HDV; HIV; liver transplantationChronic hepatitiRAPID VIROLOGICAL RESPONSEbusinessCHRONIC HEPATITIS C; ANTIVIRAL TREATMENT; CLINICAL PRACTICE GUIDELINESdescription
It is increasingly clear that a tailored therapeutic approach to patients with hepatitis C virus infection is needed. Success rates in difficult to treat and low-responsive hepatitis C virus patients are not completely satisfactory, and there is the need to optimise treatment duration and intensity in patients with the highest likelihood of response. In addition, the management of special patient categories originally excluded from phase III registration trials needs to be critically re-evaluated. This article reports the recommendations for the treatment of hepatitis C virus infection on an individual basis, drafted by experts of three scientific societies.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2010-02-01 |